Pricing Log in Create free account

Alpha Cognition Inc. (ACOG) vs Keros Therapeutics, Inc. (KROS)

Alpha Cognition Inc. and Keros Therapeutics, Inc. are both Biotechnology companies. Alpha Cognition Inc. and Keros Therapeutics, Inc. are of similar size ($183.7M and $180.5M). Keros Therapeutics, Inc. has the higher net margin (−112.2% vs −137.7%) and the lower return on invested capital (−233.2% vs −144.7%). Across the 15 metrics below, Keros Therapeutics, Inc. leads on 12 and Alpha Cognition Inc. on 3.

Valuation

Metric ACOG KROS Biotechnology median
P/E n/m n/m 10.60
P/S 11.83 3.38 9.40
P/B 3.41 0.67 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 1.02 0.66
EV/Sales 9.18 (1.33) 9.02
Earnings yield (11.58%) (30.02%) (32.88%)
Free cash flow yield (20.54%) (25.93%) (23.13%)

Profitability

Metric ACOG KROS Biotechnology median
Gross margin 90.37% 100.00% 68.51%
Operating margin (174.70%) (133.16%) 0.00%
Net margin (137.69%) (112.18%) 0.00%
Free cash flow margin (242.99%) (87.73%) 0.00%
Return on equity (49.53%) (12.56%) (51.96%)
Return on assets (38.33%) (11.76%) (46.06%)
Return on invested capital (144.65%) (233.22%) 0.00%

Growth

Metric ACOG KROS Biotechnology median
Revenue growth (TTM) — (76.37%) 6.76%
EPS growth (last fiscal year) 42.08% 146.00% 29.88%
Revenue growth, 5-year CAGR — 89.45% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACOG KROS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.03 18.14 4.97
Net debt to EBITDA 2.92 (4.16) 1.01

Dividend

Metric ACOG KROS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACOG KROS Biotechnology median
Market cap 180.54m 183.68m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack